"Official medicines" is the best online drugstore.

World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system.

The meds you need, reliable and hassle free! Top products of top brands.

The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe!


(meth-IMM-uh-zole)
Tapazole
Class: Antithyroid

 Action Inhibits synthesis of thyroid hormones.

 Indications Long-term therapy of hyperthyroidism; amelioration of hyperthyroidism in preparation for subtotal thyroidectomy or radioactive iodine therapy.

 Contraindications Use in nursing women.

 Route/Dosage

ADULTS: Initial dose: PO 15–60 mg/day in 3 equal doses at approximately 8-hr intervals. Maintenance: PO 5–15 mg/day. CHILDREN: Initial dose: PO 0.4 mg/kg/day. MAINTENANCE: PO Approximately ½ initial dose. Alternately, children may be given 0.5–0.7 mg/kg/day in 3 divided doses as initial therapy and 1/3–2/3 of initial dose for maintenance.

 Interactions

Anticoagulants: May decrease or increase anticoagulant action. Beta blockers: May increase effects of beta blockers, resulting in toxicity. Digoxin: May cause increase in effects of digitalis glycosides, including toxicity. Theophyllines: May alter theophylline clearance in hyperthyroid or hypothyroid patients.

 Lab Test Interferences None well documented.

 Adverse Reactions

CNS: Paresthesias; neuritis; headache; vertigo; drowsiness; neuropathies; NS stimulation; depression. DERM: Rash; urticaria; pruritus; erythema nodosum; skin pigmentation; xfoliative dermatitis; lupus-like syndrome including splenomegaly, hepatitis, periarteritis, hypoprothrombinemia and bleeding. EENT: Loss of taste; sialadenopathy. GI: Nausea; vomiting; epigastric distress. GU: Nephritis. HEPA: Jaundice; hepatitis. HEMA: Inhibition of myelopoiesis (eg, agranulocytosis, granulocytopenia, thrombocytopenia); aplastic anemia; hypoprothrombinemia; periarteritis. OTHER: Abnormal hair loss; arthralgia; myalgia; edema; lymphadenopathy; drug fever; interstitial pneumonitis; insulin autoimmune syndrome.

 Precautions

Pregnancy: Category D. Lactation: Avoid nursing. Agranulocytosis: Potentially most serious side effect. Discontinue drug in presence of agranulocytosis, aplastic anemia, hepatitis, fever or exfoliative dermatitis. Hemorrhage: May cause hypoprothrombinemia and bleeding. Monitor PT.

PATIENT CARE CONSIDERATIONS

 Administration/Storage

  • Administer around clock in 3 equal doses (ie, q 8 hr).
  • Administer each dose with same amount of food to facilitate uniform absorption.
  • Store in light-resistant container at room temperature.

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Assess for history of liver disease.
  • Assess symptoms of hyperthyroidism that patient is experiencing.
  • Obtain baseline vital signs and monitor during treatment.
  • Obtain baseline hepatic blood work including bilirubin and liver enzymes.
  • Obtain baseline CBC and monitor carefully during first 2 months of treatment.
  • Obtain baseline thyroid levels and monitor monthly initially and q 2–3 mo for long-term therapy.
  • Monitor drug’s effects on hyperthyroid symptoms.
  • Monitor PT, especially before surgery, to assess increased risk of bleeding.
  • Observe for potential adverse reactions including rash or fever, and notify physician if any occur.
OVERDOSAGE: SIGNS & SYMPTOMS
  Nausea, vomiting, epigastric distress, headache, fever, arthralgia, pruritus, edema, pancytopenia, agranulocytosis, exfoliative dermatitis, hepatitis, neuropathies, CNS stimulation or depression.

 Patient/Family Education

  • Instruct patient in importance of taking proper dose exactly as scheduled.
  • Advise patient not to stop, start or adjust dose of any medications, including otc, without discussing with physician.
  • Explain to patient the importance of complying with follow-up appointments and lab work.
  • Instruct patient to check pulse daily.
  • Advise patient that iodine-restrictive diet may be necessary.
  • Inform patient that response to therapy may take months.
  • Instruct patient to report these symptoms to physician: rash, fever, sore throat, bruising or signs of infection or jaundice.
  • Advise patient that drug may cause drowsiness and to use caution while driving or performing other tasks requiring mental alertness.

Popularity: 7% [?]


If you're still unable to find appropriate information in the article, please use search form below